Shi Si Medicine Group's Dexamethasone Sodium Phosphate Injection Receives Drug Registration Certificate for Production.

ShiSi Pharmaceutical Group announcement, the group has obtained the drug production registration approval for the injection of Doxapram Hydrochloride by the China National Medical Products Administration. It belongs to Class 3 chemical drugs and is considered equivalent to passing consistency evaluation. The group's Doxapram Hydrochloride injection is the first domestic enterprise to obtain approval, mainly used for the treatment of respiratory failure.